Thank you all for your replies. I am Er/Pr- so I guess this test would not apply to me. I don't know enough about it though to understand what the difference would be. Maybe it is something that they have measured in relation to er+ and the use of Tomoxifen and that is the only factor that has been measured. I would like to see more studies showing more specifics on recurance in locally advanced er/pr- her2+ if there are any credible ones out there. It may still be too early in the game to have these available. I guess we would all like to have a crystal ball.
Thanks, Alice
|